Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE
- 1 August 2011
- journal article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 140 (2), 366-373
- https://doi.org/10.1378/chest.10-1599
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic strokeThrombosis and Haemostasis, 2010
- Can heparin‐induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttalJournal of Thrombosis and Haemostasis, 2008
- Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)Thrombosis and Haemostasis, 2008
- Fondaparinux for the treatment of patients with acute heparininduced thrombocytopeniaThrombosis and Haemostasis, 2008
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxThe New England Journal of Medicine, 2007
- Heparin-Induced ThrombocytopeniaThe New England Journal of Medicine, 2006
- Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settingsJournal of Thrombosis and Haemostasis, 2006
- Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin‐dependent antibodiesBritish Journal of Haematology, 2005
- The epitope specificity of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinThe New England Journal of Medicine, 1995